Becker's Healthcare February 10, 2022
Naomi Diaz

As demand for COVID-19 testing and vaccination dwindles, CVS Health must prove that it can continue to grow and maintain customers, CNBC reported Feb. 9.

Pandemic-related services drove CVS sales and customer engagement as the pharmacy administered more than 32 million COVID-19 tests and more than 59 million COVID-19 vaccines. But as cases around the country decrease, CVS will need to work on maintaining its ambitions of becoming a healthcare destination, according to the report.

On a Feb. 9 earnings call, Shawn Guertin, chief financial officer of CVS, said he expects COVID-19 vaccines to drop by 70 percent to 80 percent and in-store testing to decline by 40 percent to 50 percent, compared to 2021.

The only exception coming...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Payer, Pharma, Pharma / Biotech
Major health insurance companies are nearing too big to fail status
Elevance Health sees double-digit profit growth in Q1, posting $2.2 B in earnings
Elevance Health posts $2.2B profit in Q1
Elevance Health Boosts Behavioral Health Biz with $740M State Contracts
Elevance's Healths new $4B primary care venture: 5 things to know

Share This Article